These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 8831712)

  • 21. Recombinant human antibodies against aldehyde-modified apolipoprotein B-100 peptide sequences inhibit atherosclerosis.
    Schiopu A; Bengtsson J; Söderberg I; Janciauskiene S; Lindgren S; Ares MP; Shah PK; Carlsson R; Nilsson J; Fredrikson GN
    Circulation; 2004 Oct; 110(14):2047-52. PubMed ID: 15451805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo and in vitro evidence for the glycoxidation of low density lipoprotein in human atherosclerotic plaques.
    Imanaga Y; Sakata N; Takebayashi S; Matsunaga A; Sasaki J; Arakawa K; Nagai R; Horiuchi S; Itabe H; Takano T
    Atherosclerosis; 2000 Jun; 150(2):343-55. PubMed ID: 10856526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies on epitopes on low-density lipoprotein modified by 4-hydroxynonenal. Biochemical characterization and determination.
    Chen Q; Esterbauer H; Jürgens G
    Biochem J; 1992 Nov; 288 ( Pt 1)(Pt 1):249-54. PubMed ID: 1280111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low-density lipoprotein (LDL)-antioxidant lignans from Myristica fragrans seeds.
    Kwon HS; Kim MJ; Jeong HJ; Yang MS; Park KH; Jeong TS; Lee WS
    Bioorg Med Chem Lett; 2008 Jan; 18(1):194-8. PubMed ID: 17998162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxidative and malondialdehyde modification of low-density lipoprotein: a comparative study.
    Chen Y; Zhou M; Liu S; Ding Z; Lou N; Pang Z; Wan J
    Br J Biomed Sci; 1997 Sep; 54(3):159-65. PubMed ID: 9499592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of modified low density lipoprotein subfractions by capillary isotachophoresis.
    Zorn U; Haug C; Celik E; Wennauer R; Schmid-Kotsas A; Bachem MG; Grünert A
    Electrophoresis; 2001 Apr; 22(6):1143-9. PubMed ID: 11358140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inactivation of cathepsin B by oxidized LDL involves complex formation induced by binding of putative reactive sites exposed at low pH to thiols on the enzyme.
    O'Neil J; Hoppe G; Sayre LM; Hoff HF
    Free Radic Biol Med; 1997; 23(2):215-25. PubMed ID: 9199883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autoantibodies to oxidized low density lipoprotein: the relationship to low density lipoprotein fatty acid composition in diabetes.
    Griffin ME; McInerney D; Fraser A; Johnson AH; Collins PB; Owens D; Tomkin GH
    Diabet Med; 1997 Sep; 14(9):741-7. PubMed ID: 9300223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studying low-density lipoprotein-monoclonal antibody complexes using dynamic laser light scattering and analytical ultracentrifugation.
    Gutierrez MM; Tsai SW; Phillips ML; Curtiss LK; Milne RW; Schumaker VN
    Biochemistry; 1999 Jan; 38(4):1284-92. PubMed ID: 9930989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oxidation of low-density lipoproteins produces levuglandin-protein adducts.
    Salomon RG; Subbanagounder G; Singh U; O'Neil J; Hoff HF
    Chem Res Toxicol; 1997 Jul; 10(7):750-9. PubMed ID: 9250408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Higher reactivity of apolipoprotein B-100 and alpha-tocopherol compared to sialic acid moiety of low-density lipoprotein (LDL) in radical reaction.
    Matsukawa N; Nariyama Y; Hashimoto R; Kojo S
    Bioorg Med Chem; 2003 Sep; 11(18):4009-13. PubMed ID: 12927863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunologic detection and measurement of glycated apolipoprotein B with site specific monoclonal antibodies.
    Shea EA; Cohen MP
    J Immunol Methods; 1993 Jun; 162(1):85-95. PubMed ID: 8509655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunologic detection and measurement of hypochlorite-modified LDL with specific monoclonal antibodies.
    Malle E; Hazell L; Stocker R; Sattler W; Esterbauer H; Waeg G
    Arterioscler Thromb Vasc Biol; 1995 Jul; 15(7):982-9. PubMed ID: 7541296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of oxidized low density lipoprotein in human renal biopsies.
    Lee HS; Kim YS
    Kidney Int; 1998 Sep; 54(3):848-56. PubMed ID: 9734609
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The production and use of monoclonal antibodies to measure apolipoprotein B by a competitive enzyme-linked immunoassay.
    Waterson M; Samuel L; Miller E; Norman M
    Ann Clin Biochem; 1987 May; 24 ( Pt 3)():301-8. PubMed ID: 3111342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simple and practical sandwich-type enzyme immunoassay for human oxidatively modified low density lipoprotein using antioxidized phosphatidylcholine monoclonal antibody and antihuman apolipoprotein-B antibody.
    Kohno H; Sueshige N; Oguri K; Izumidate H; Masunari T; Kawamura M; Itabe H; Takano T; Hasegawa A; Nagai R
    Clin Biochem; 2000 Jun; 33(4):243-53. PubMed ID: 10936581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polyclonal antibodies to a fluorescent 4-hydroxy-2-nonenal (HNE)-derived lysine-lysine cross-link: characterization and application to HNE-treated protein and in vitro oxidized low-density lipoprotein.
    Xu G; Liu Y; Sayre LM
    Chem Res Toxicol; 2000 May; 13(5):406-13. PubMed ID: 10813658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of modified apolipoprotein B-100 structures formed in oxidized low-density lipoprotein using LC-MS/MS.
    Obama T; Kato R; Masuda Y; Takahashi K; Aiuchi T; Itabe H
    Proteomics; 2007 Jun; 7(13):2132-41. PubMed ID: 17549798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein modification by lipid peroxidation products: formation of malondialdehyde-derived N(epsilon)-(2-propenol)lysine in proteins.
    Uchida K; Sakai K; Itakura K; Osawa T; Toyokuni S
    Arch Biochem Biophys; 1997 Oct; 346(1):45-52. PubMed ID: 9328283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sensitive detection of oxidatively modified low density lipoprotein using a monoclonal antibody.
    Itabe H; Yamamoto H; Imanaka T; Shimamura K; Uchiyama H; Kimura J; Sanaka T; Hata Y; Takano T
    J Lipid Res; 1996 Jan; 37(1):45-53. PubMed ID: 8820101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.